About Acenxion Biosystems

Acenxion Biosystems is a privately funded company that develops automated systems for phenotypic antimicrobial susceptibility testing (AST) and bacterial detection in blood cultures. Seamlessly fitting into current clinical workflows, Acenxion’s scalable fAST system reduces the time required for phenotypic testing to just 4-6 hours, allowing clinicians rapid use of a precise, targeted treatment. Acenxion’s technology improves patient outcomes, reduces healthcare costs, and reduces the spread of View more